Sarah Johnson

FDA investigator

Appears on 4 documents from 2019 to 2022, mostly at sites in Singapore. Most often cites written procedures; deviations (21 CFR 211.100).

4
Documents on file
2.8
Observations per 483
2019
First seen
2022
Most recent

What they cite most

From 11 observations

Activity by year

2019: 1, 2020: 1, 2021: 1, 2022: 1

Where

Singapore 2 · California 1 · Ireland 1

Is Sarah Johnson coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Revance Therapeutics, Inc.Jul 15, 2022 · Newark, California
483 Janssen Sciences Ireland UCApr 30, 2021 · Cork, Ireland
483 Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.Feb 15, 2020 · Singapore, Singapore
483 LONZA BIOLOGICS TUAS PTE. LTD.Jun 18, 2019 · Singapore, Singapore

About this profile

What does Sarah Johnson inspect?

Sarah Johnson appears on 4 documents on file covering 4 sites, mostly in Singapore.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Sarah Johnson is dated Jul 15, 2022.